Avalon Research Development vs Total Other Income Expense Net Analysis

ALBT Stock

2.70 0.21 8.43%

Avalon GloboCare financial indicator trend analysis is way more than just evaluating Avalon GloboCare Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Avalon GloboCare Corp is a good investment. Please check the relationship between Avalon GloboCare Research Development and its Total Other Income Expense Net accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avalon GloboCare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Research Development vs Total Other Income Expense Net

Research Development vs Total Other Income Expense Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Avalon GloboCare Corp Research Development account and Total Other Income Expense Net. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Avalon GloboCare's Research Development and Total Other Income Expense Net is 0.54. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Total Other Income Expense Net in the same time period over historical financial statements of Avalon GloboCare Corp, assuming nothing else is changed. The correlation between historical values of Avalon GloboCare's Research Development and Total Other Income Expense Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Avalon GloboCare Corp are associated (or correlated) with its Total Other Income Expense Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Other Income Expense Net has no effect on the direction of Research Development i.e., Avalon GloboCare's Research Development and Total Other Income Expense Net go up and down completely randomly.

Correlation Coefficient

0.54

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Research Development

Total Other Income Expense Net

Most indicators from Avalon GloboCare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Avalon GloboCare Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avalon GloboCare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Selling General Administrative is likely to gain to about 7.3 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 8 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	414.5K	272.7K	238.2K	283.5K
Total Revenue	1.4M	1.2M	1.3M	1.4M

Gross Profit Total Revenue

Avalon GloboCare fundamental ratios Correlations

	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Non Current Liabilities Total	Total Liab	Short Term Debt	Common Stock	Total Assets	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Current Assets	Other Current Liab	Property Plant And Equipment Net	Non Current Assets Total	Net Receivables	Inventory	Other Current Assets	Current Deferred Revenue	Non Currrent Assets Other	Intangible Assets	Net Tangible Assets
Short Long Term Debt Total		0.89	0.52	0.91	-0.95	0.97	0.97	0.68	0.06	0.78	0.27	0.03	0.03	0.79	0.82	0.02	0.77	0.49	0.83	0.62	-0.8	0.05	0.13	0.25	-0.86	-0.83
Total Current Liabilities	0.89		0.59	0.77	-0.85	0.89	0.96	0.7	0.23	0.82	0.15	0.21	0.21	0.81	0.76	0.15	0.92	0.47	0.85	0.51	-0.83	-0.03	0.03	0.22	-0.75	-0.74
Total Stockholder Equity	0.52	0.59		0.25	-0.53	0.58	0.59	0.5	0.39	0.89	0.14	0.69	0.69	0.81	0.65	0.71	0.55	0.33	0.82	0.26	-0.85	0.21	0.66	0.61	-0.66	-0.43
Net Debt	0.91	0.77	0.25		-0.9	0.9	0.88	0.46	-0.17	0.58	0.24	-0.37	-0.37	0.55	0.72	-0.37	0.65	0.46	0.68	0.63	-0.63	0.02	0.01	0.14	-0.79	-0.79
Retained Earnings	-0.95	-0.85	-0.53	-0.9		-0.97	-0.96	-0.48	-0.08	-0.81	-0.27	0.02	0.02	-0.82	-0.93	0.01	-0.81	-0.57	-0.87	-0.6	0.78	0.07	-0.21	-0.46	0.91	0.93
Non Current Liabilities Total	0.97	0.89	0.58	0.9	-0.97		0.98	0.55	0.09	0.84	0.34	0.04	0.04	0.83	0.88	0.03	0.82	0.56	0.89	0.63	-0.83	0.03	0.27	0.41	-0.9	-0.89
Total Liab	0.97	0.96	0.59	0.88	-0.96	0.98		0.63	0.15	0.85	0.27	0.09	0.09	0.84	0.86	0.07	0.88	0.55	0.89	0.6	-0.85	0.0	0.16	0.34	-0.87	-0.86
Short Term Debt	0.68	0.7	0.5	0.46	-0.48	0.55	0.63		0.13	0.54	-0.12	0.38	0.38	0.55	0.32	0.32	0.45	0.04	0.51	0.28	-0.65	0.25	-0.14	-0.25	-0.44	-0.23
Common Stock	0.06	0.23	0.39	-0.17	-0.08	0.09	0.15	0.13		0.35	0.52	0.59	0.59	0.56	0.31	0.69	0.34	0.69	0.24	-0.05	-0.03	-0.61	0.31	0.4	-0.32	-0.26
Total Assets	0.78	0.82	0.89	0.58	-0.81	0.84	0.85	0.54	0.35		0.27	0.46	0.46	0.95	0.89	0.46	0.83	0.5	0.99	0.52	-0.91	0.06	0.48	0.6	-0.83	-0.75
Accounts Payable	0.27	0.15	0.14	0.24	-0.27	0.34	0.27	-0.12	0.52	0.27		0.03	0.03	0.41	0.37	0.15	0.26	0.77	0.26	0.34	0.02	-0.37	0.52	0.4	-0.44	-0.49
Cash	0.03	0.21	0.69	-0.37	0.02	0.04	0.09	0.38	0.59	0.46	0.03		1.0	0.49	0.16	0.97	0.24	0.04	0.3	-0.14	-0.35	0.07	0.36	0.34	-0.06	0.03
Cash And Short Term Investments	0.03	0.21	0.69	-0.37	0.02	0.04	0.09	0.38	0.59	0.46	0.03	1.0		0.49	0.16	0.97	0.24	0.04	0.3	-0.14	-0.35	0.07	0.36	0.34	-0.06	0.03
Common Stock Shares Outstanding	0.79	0.81	0.81	0.55	-0.82	0.83	0.84	0.55	0.56	0.95	0.41	0.49	0.49		0.9	0.53	0.84	0.67	0.92	0.49	-0.78	-0.16	0.43	0.6	-0.87	-0.81
Other Stockholder Equity	0.82	0.76	0.65	0.72	-0.93	0.88	0.86	0.32	0.31	0.89	0.37	0.16	0.16	0.9		0.2	0.84	0.66	0.92	0.56	-0.74	-0.2	0.37	0.68	-0.9	-0.95
Total Current Assets	0.02	0.15	0.71	-0.37	0.01	0.03	0.07	0.32	0.69	0.46	0.15	0.97	0.97	0.53	0.2		0.19	0.18	0.31	-0.11	-0.31	0.0	0.48	0.43	-0.16	-0.01
Other Current Liab	0.77	0.92	0.55	0.65	-0.81	0.82	0.88	0.45	0.34	0.83	0.26	0.24	0.24	0.84	0.84	0.19		0.55	0.86	0.55	-0.72	-0.18	0.07	0.41	-0.69	-0.83
Property Plant And Equipment Net	0.49	0.47	0.33	0.46	-0.57	0.56	0.55	0.04	0.69	0.5	0.77	0.04	0.04	0.67	0.66	0.18	0.55		0.5	0.35	-0.23	-0.59	0.43	0.58	-0.75	-0.75
Non Current Assets Total	0.83	0.85	0.82	0.68	-0.87	0.89	0.89	0.51	0.24	0.99	0.26	0.3	0.3	0.92	0.92	0.31	0.86	0.5		0.58	-0.91	0.06	0.42	0.58	-0.86	-0.81
Net Receivables	0.62	0.51	0.26	0.63	-0.6	0.63	0.6	0.28	-0.05	0.52	0.34	-0.14	-0.14	0.49	0.56	-0.11	0.55	0.35	0.58		-0.43	0.33	0.11	0.21	-0.58	-0.63
Inventory	-0.8	-0.83	-0.85	-0.63	0.78	-0.83	-0.85	-0.65	-0.03	-0.91	0.02	-0.35	-0.35	-0.78	-0.74	-0.31	-0.72	-0.23	-0.91	-0.43		-0.32	-0.37	-0.41	0.73	0.59
Other Current Assets	0.05	-0.03	0.21	0.02	0.07	0.03	0.0	0.25	-0.61	0.06	-0.37	0.07	0.07	-0.16	-0.2	0.0	-0.18	-0.59	0.06	0.33	-0.32		0.12	-0.19	0.13	0.28
Current Deferred Revenue	0.13	0.03	0.66	0.01	-0.21	0.27	0.16	-0.14	0.31	0.48	0.52	0.36	0.36	0.43	0.37	0.48	0.07	0.43	0.42	0.11	-0.37	0.12		0.76	-0.46	-0.26
Non Currrent Assets Other	0.25	0.22	0.61	0.14	-0.46	0.41	0.34	-0.25	0.4	0.6	0.4	0.34	0.34	0.6	0.68	0.43	0.41	0.58	0.58	0.21	-0.41	-0.19	0.76		-0.57	-0.61
Intangible Assets	-0.86	-0.75	-0.66	-0.79	0.91	-0.9	-0.87	-0.44	-0.32	-0.83	-0.44	-0.06	-0.06	-0.87	-0.9	-0.16	-0.69	-0.75	-0.86	-0.58	0.73	0.13	-0.46	-0.57		0.87
Net Tangible Assets	-0.83	-0.74	-0.43	-0.79	0.93	-0.89	-0.86	-0.23	-0.26	-0.75	-0.49	0.03	0.03	-0.81	-0.95	-0.01	-0.83	-0.75	-0.81	-0.63	0.59	0.28	-0.26	-0.61	0.87

Click cells to compare fundamentals

Avalon GloboCare Account Relationship Matchups

Avalon GloboCare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Short Long Term Debt Total	3.2M	3.7M	3.3M	4.6M	8.5M	8.9M
Total Current Liabilities	2.8M	2.6M	4.4M	3.6M	6.8M	7.1M
Total Stockholder Equity	4.5M	4.1M	3.1M	11.2M	7.4M	5.9M
Net Debt	2.4M	3.0M	2.5M	2.6M	8.2M	8.6M
Retained Earnings	(29.4M)	(42.0M)	(51.1M)	(63.1M)	(79.8M)	(75.8M)
Non Current Liabilities Total	3.2M	3.7M	2.8M	5.0M	6.5M	6.8M
Total Liab	6.0M	6.2M	7.2M	8.6M	13.2M	13.9M
Common Stock	7.7K	8.3K	8.9K	1.0K	1.1K	1.0K
Total Assets	10.5M	10.4M	10.2M	19.8M	20.6M	12.4M
Accounts Payable	84.3K	87.2K	0.0	11.8K	13.6K	12.9K
Cash	764.9K	726.6K	807.5K	2.0M	285.4K	271.1K
Cash And Short Term Investments	764.9K	726.6K	807.5K	2.0M	285.4K	271.1K
Common Stock Shares Outstanding	7.5M	8.0M	8.5M	9.3M	10.5M	7.7M
Liabilities And Stockholders Equity	10.5M	10.4M	10.2M	19.8M	20.6M	12.4M
Other Stockholder Equity	34.1M	46.3M	54.4M	65.4M	67.4M	37.4M
Total Current Assets	1.6M	1.3M	1.3M	2.4M	285.4K	271.1K
Other Current Liab	2.8M	2.4M	4.0M	3.5M	4.6M	2.9M
Property Plant And Equipment Net	601.4K	616.4K	506.9K	149.2K	166.3K	321.5K
Non Current Assets Total	8.9M	9.1M	8.9M	17.4M	19.9M	11.5M
Net Receivables	243.9K	35.4K	90.9K	134.6K	234.7K	125.2K
Inventory	504.2K	493.3K	430.0K	(390.3K)	(351.3K)	(333.7K)
Other Current Assets	58.2K	(528.7K)	(520.8K)	248.0K	155.7K	163.5K
Accumulated Other Comprehensive Income	(251.2K)	(183.9K)	(158.7K)	(206.6K)	(225.1K)	(236.4K)
Non Currrent Assets Other	7.8M	7.9M	7.9M	16.7M	454.0K	431.3K
Long Term Debt	3.2M	3.6M	2.8M	4.6M	6.4M	3.9M
Net Invested Capital	7.7M	7.7M	6.2M	6.7M	(4.3M)	(4.0M)
Long Term Investments	483.1K	521.8K	515.6K	485.0K	12.1M	12.7M
Capital Stock	7.7K	8.3K	8.9K	9.0M	20.0M	21.0M
Net Working Capital	(1.3M)	(1.3M)	(3.1M)	(1.2M)	(5.9M)	(5.6M)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Avalon Stock Analysis

When running Avalon GloboCare's price analysis, check to measure Avalon GloboCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avalon GloboCare is operating at the current time. Most of Avalon GloboCare's value examination focuses on studying past and present price action to predict the probability of Avalon GloboCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avalon GloboCare's price. Additionally, you may evaluate how the addition of Avalon GloboCare to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC